Trial Details
Trial status:
Recruitment start date:
01/04/2009
Funder:
CRUK & The Bobby Moore Fund
Sponsor:
Chief Investigator:
Dr Simon Gollins
Recruitment target:
80
EudraCT number:
Contact details:
ctc.excite@ucl.ac.uk
Lay summary:
EXCITE
Erbitux, Xeloda, Campto, Irradiation Then Excision for locally advanced rectal cancer (North West/North Wales Clinical Oncology Group-04 on behalf of the NCRI rectal cancer subgroup)
Description
Design:
Treatment:
Key inclusion/exclusion criteria:
Duration of recruitment:
Aim

Trial protocols
Trial protocols must not be applied to patients treated outside trials. UCL CTC can only ensure that approved trial investigators are provided with amendments to protocols.
NameVersionCurrent versRelease dateDownload
EXCITE Protocol v4.3 _21AUG15_24082017_0.pdf4.3 Current 21/08/2015
Trial documents
No documents have been currently made available for download
Contact Us
Cancer Research UK & UCL Cancer Trials Centre
University College London
90 Tottenham Court Road
London
W1T 4TJ

View map
Email:
ctc.enquiries@ucl.ac.uk
Telephone:
+44 (0)20 7679 9898 (General CTC Enquiries)
Fax:
020 7679 9899
University College London, Gower Street, London, WC1E 6BT +44 (0)20 7679 2000

Copyright © 2024 UCL | Disclaimer | Freedom of Information | Accessibility | Privacy | Cookies | Contact Us